Alzheimer’s β-peptide oligomer formation at physiologic concentrations
- 1 December 2004
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 335 (1) , 81-90
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Neurofibrillary Tangles Mediate the Association of Amyloid Load With Clinical Alzheimer Disease and Level of Cognitive FunctionArchives of Neurology, 2004
- Zeroing in on the Pathogenic Form of α-Synuclein and Its Mechanism of Neurotoxicity in Parkinson's DiseaseBiochemistry, 2003
- Soluble amyloid oligomers: a common cause of neurodegeneration?The Lancet Neurology, 2003
- Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s diseaseNeurology, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?Trends in Neurosciences, 2001
- Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive DeclineJAMA, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- The Mean Aβ Load in the Hippocampus Correlates with Duration and Severity of Dementia in Subgroups of Alzheimer DiseaseJournal of Neuropathology & Experimental Neurology, 1997